亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!

Prognostic Value of Left Atrial Calcification After Catheter Ablation for Atrial Fibrillation

医学 心房颤动 内科学 导管消融 心脏病学 烧蚀 冲程(发动机) 心力衰竭 外科 机械工程 工程类
作者
Daisuke Yakabe,Kazuhiro Ohtani,Yoshikazu Fukuyama,Masahiro Araki,Taiki Higo,Toshihiro Nakamura,Hiroyuki Tsutsui
出处
期刊:JACC: Clinical Electrophysiology [Elsevier BV]
卷期号:9 (7): 1108-1117 被引量:5
标识
DOI:10.1016/j.jacep.2022.11.016
摘要

Left atrial calcification (LAC) has occasionally been observed in patients who underwent catheter ablation for atrial fibrillation (AF) by chest computed tomography (CT). However, the evidence regarding the clinical impact of LAC in patients with AF is lacking.This study aims to investigate the prevalence of LAC in AF patients and evaluate its clinical significance after AF ablation.This observational registry included AF patients who received computed tomography and serial transthoracic echocardiography between January 2010 and November 2017. The primary composite outcome included cardiovascular death, hospitalization for worsening heart failure, and ischemic stroke.Among 534 patients (age 72 ± 13 years, 62.5% men) who met the inclusion criteria, 31 (5.8%) had LAC. In multivariable analysis, AF ablation was associated with an 11.8-fold (OR: 11.8; 95% CI: 2.03-227.65) increased risk of the development of LAC in AF patients. Among 218 patients with AF ablation, LAC was detected in 30 (13.8%) patients. Prior stroke (HR: 2.73; 95% CI: 1.08-6.93) and multiple ablation procedures (HR: 4.21; 95% CI: 1.63-10.87) were independently associated with the development of LAC in AF-ablation patients. During a median follow-up of 5.8 years, the primary composite outcome occurred in 11 patients in the LAC group (39.8 per 1,000 person-years) and 10 patients in the non-LAC group (8.9 per 1,000 person-years). The adjusted HR for the primary composite outcome in the LAC group, as compared with the non-LAC group, was 2.81 (95% CI: 1.16-6.84; P = 0.02).The presence of LAC was a significant and independent prognostic factor for identifying major adverse cardiovascular events after AF ablation.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
3秒前
4秒前
懂事梨发布了新的文献求助10
9秒前
12秒前
领导范儿应助懂事梨采纳,获得10
14秒前
17秒前
19秒前
20秒前
鲤鱼从安发布了新的文献求助10
22秒前
29秒前
Hello应助Aimeee采纳,获得10
36秒前
38秒前
46秒前
T-SL发布了新的文献求助10
48秒前
短短大王发布了新的文献求助10
52秒前
54秒前
池雨完成签到 ,获得积分10
57秒前
科目三应助xiaoliaikeyan采纳,获得10
57秒前
土大款应助科研通管家采纳,获得10
58秒前
1分钟前
仰勒完成签到 ,获得积分10
1分钟前
1分钟前
1分钟前
li完成签到 ,获得积分10
1分钟前
发十篇完成签到 ,获得积分10
1分钟前
1分钟前
1分钟前
1分钟前
跌跌撞撞完成签到,获得积分10
1分钟前
官方v发布了新的文献求助10
1分钟前
跌跌撞撞发布了新的文献求助10
1分钟前
xiaoliaikeyan发布了新的文献求助10
1分钟前
1分钟前
虞头星星发布了新的文献求助10
1分钟前
CipherSage应助官方v采纳,获得10
1分钟前
JamesPei应助虞头星星采纳,获得10
1分钟前
1分钟前
缥缈的愫完成签到 ,获得积分10
1分钟前
顾矜应助合适研发看采纳,获得10
1分钟前
薛刀刀发布了新的文献求助10
1分钟前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Prompt Engineering for Clinicians: Harnessing AI in Everyday Medical Practice 600
REAL-WORLD EFFICACY AND GENOMIC LANDSCAPE OF POLATUZUMA VEDOTIN-BASED FIRST-LINE THERAPY IN DIFFUSE LARGE B-CELL LYMPHOMA: A FOCUS ON TP53 MUTATIONS AND TREATMENT RESPONSE 500
Handbook of Luminescence Dating 500
Safety Pharmacology 500
《KNN基无铅压电陶瓷电学性能优化与物理机理研究》 500
Elgar Concise Encyclopedia of Space Law 400
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 工程类 有机化学 计算机科学 化学工程 生物化学 物理 内科学 复合材料 催化作用 光电子学 物理化学 电极 细胞生物学 基因 遗传学
热门帖子
关注 科研通微信公众号,转发送积分 6945972
求助须知:如何正确求助?哪些是违规求助? 8631226
关于积分的说明 18306731
捐赠科研通 6382688
什么是DOI,文献DOI怎么找? 3079924
关于科研通互助平台的介绍 2121798
邀请新用户注册赠送积分活动 2056860